Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: "Expect Focus on Oncology Studies; Cost Containment Efforts"
Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: Expect Focus on Oncology Studies; Cost Containment Efforts
Stay updated with breaking news from Guy Cipriani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aethlon Medical (NASDAQ: AEMD) Research/Media Alert: Expect Focus on Oncology Studies; Cost Containment Efforts
SAN DIEGO, June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases,... | June 10, 2023
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and...
Operator: Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2023 Earnings and Corporate Update Call. All participants will be in listen-only mode.